Company intelligence / Profile preview

Ganzimmun Diagnostics

Mainz, Rhineland-Palatinate, Germany

Ownership: Private
Employees: ~430
Development stage: Other

Overview

Ganzimmun Diagnostics is a leading European laboratory specializing in comprehensive, innovative diagnostics for preventive and complementary medicine, offering over 4,000 laboratory parameters and processing approximately 6,000 laboratory orders per day. It is recognized for allergy, food intolerance, endocrine, immunological, gastrointestinal, mitochondrial, neuroendocrine, cardiovascular, infectious disease, and genetic diagnostics, as well as colorectal cancer screening tests such as ColoAlert[1][2][5].

Modalities: Laboratory diagnosticsPreventive medicineComplementary medicineGenetic diagnosticsMicrobiome analysisMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Mainz Biomed (ColoAlert colorectal cancer screening test)

Beyond the preview

Go deeper on Ganzimmun Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganzimmun Diagnostics.

Explore the full profile